Fulcrum Therapeutics, Inc. (FULC)
NASDAQ: FULC · Real-Time Price · USD
2.990
-0.020 (-0.66%)
Nov 20, 2024, 4:00 PM EST - Market closed
Fulcrum Therapeutics Market Cap
Fulcrum Therapeutics has a market cap or net worth of $161.28 million as of November 21, 2024. Its market cap has decreased by -27.33% in one year.
Market Cap
161.28M
Enterprise Value
-86.81M
1-Year Change
-27.33%
Ranking
Category
Stock Price
$2.99
Market Cap Chart
Since July 18, 2019, Fulcrum Therapeutics's market cap has decreased from $301.64M to $161.28M, a decrease of -46.53%. That is a compound annual growth rate of -11.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 162.36M | -61.09% |
| Dec 29, 2023 | 417.30M | 10.13% |
| Dec 30, 2022 | 378.93M | -47.15% |
| Dec 31, 2021 | 716.95M | 124.42% |
| Dec 31, 2020 | 319.46M | -14.89% |
| Dec 31, 2019 | 375.37M | 24.44% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lineage Cell Therapeutics | 170.56M |
| MediWound | 170.48M |
| Greenwich LifeSciences | 167.86M |
| 2seventy bio | 166.11M |
| The Joint | 164.07M |
| Gossamer Bio | 161.71M |
| Atossa Therapeutics | 161.03M |
| Alpha Tau Medical | 160.83M |